Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-26 Purchase |
2025-03-28 08:40 am |
Rezolute Inc. | RZLT | Evans Daron CFO |
20,000 | $2.885 | $57,700 | 329,900 (Indirect Direct) |
View |
| 2024-12-18 Purchase |
2024-12-18 6:01 pm |
Rezolute Inc. | RZLT | Evans Daron CFO |
10,000 | $4.29 | $42,900 | 232,900 (Indirect Direct) |
View |
| 2024-12-12 Purchase |
2024-12-12 4:54 pm |
Rezolute Inc. | RZLT | Evans Daron CFO |
9,000 | $4.6 | $41,400 | 222,900 (Indirect Direct) |
View |
| 2025-12-09 Purchase |
2024-12-10 09:11 am |
Rezolute Inc. | RZLT | Evans Daron CFO |
10,549 | $5.04 | $53,167 | 213,900 (Indirect Direct) |
View |
| 2024-06-14 Purchase |
2024-06-14 12:06 pm |
Rezolute Inc. | RZLT | Evans Daron CFO |
40,000 | $4.0392 | $161,568 | 203,351 (Indirect Direct) |
View |
| 2024-05-29 Purchase |
2024-05-31 4:05 pm |
Rezolute Inc. | RZLT | Evans Daron CFO |
451 | $3.5 | $1,579 | 163,351 (Indirect Direct) |
View |
| 2024-05-23 Purchase |
2024-05-28 2:48 pm |
Rezolute Inc. | RZLT | Evans Daron CFO |
3,000 | $3.2227 | $9,668 | 162,900 (Indirect Direct) |
View |
| 2024-03-15 Purchase |
2024-03-19 09:17 am |
Rezolute Inc. | RZLT | Evans Daron CFO |
20,000 | $1.6915 | $33,830 | 159,900 (Indirect Direct) |
View |
| 2024-03-08 Purchase |
2024-03-08 12:37 pm |
Rezolute Inc. | RZLT | Evans Daron CFO |
50,000 | $1.9269 | $96,345 | 139,900 (Indirect Direct) |
View |
| 2024-02-16 Purchase |
2024-02-20 07:01 am |
Rezolute Inc. | RZLT | Evans Daron CFO |
50,900 | $1.3112 | $66,741 | 85,400 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-16 Option Award |
2025-02-19 9:29 pm |
N/A 2035-02-16 |
Rezolute Inc. | RZLT | Evans Daron CFO |
122,000 | $0 | 354,900 (Direct) |
View |
| 2024-09-23 Option Award |
2024-09-24 1:03 pm |
N/A 2034-09-23 |
Rezolute Inc. | RZLT | Evans Daron CFO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 12:47 pm |
N/A 2029-01-23 |
Rezolute Inc. | RZLT | Evans Daron CFO |
275,000 | $0 | 275,000 (Direct) |
View |
Ownership |
2024-01-25 12:46 pm |
N/A N/A |
Rezolute Inc. | RZLT | Evans Daron CFO |
0 | $0 | 39,000 (Direct) |
View |
| 2021-05-27 Tax Withholding(A) |
2021-06-01 5:39 pm |
N/A N/A |
NEPHROS INC | NEPH | Evans Daron CEO Specialty Renal Products |
349 | $2.7 | 8,669 (Indirect) |
View |
| 2021-05-24 Exercise |
2021-05-25 3:40 pm |
2016-06-03 2021-06-03 |
NEPHROS INC | NEPH | Evans Daron CEO of Specialty Renal Product |
2,222 | $0 | 524,458 (Indirect) |
View |
| 2021-05-24 Exercise |
2021-05-25 3:40 pm |
N/A N/A |
NEPHROS INC | NEPH | Evans Daron CEO of Specialty Renal Product |
1,111 | $2.7 | 524,458 (Indirect) |
View |